Governance of the cosmetic surgery and cosmetic treatments industries remains a hot topic of debate.
While there have been numerous investigations, reports and recommendations, the industry has yet to make the seismic changes required to protect patients.
The Royal College of Surgeons (RCS) and Cosmetic Surgery Interspeciality Committee (CSIC) have been working together with other stakeholders to develop proposals to better protect cosmetic surgery patients.
They have now issued a consultation paper in order to seek views on their proposals.
Read the RCS CSIC consultation document in full.
The stated objectives of the group are to improve the quality of care provided to cosmetic surgery patients by supporting the key parties involved:
- patients – to make informed decisions about their surgeon and provider
- surgeons – to identify, reflect on and share best practice
- cosmetic surgery providers – to assess quality and safety of their services
- regulators – to assure themselves of the quality of care on offer
The CSIC plan to do this by:
- Standards for training and practice – At present, to undertake cosmetic surgery independently in the private sector the person must be registered with and licensed by the General Medical Council (GMC) and must be on the GMC’s specialist register. The group aims to ensure that surgeons only perform cosmetic surgical procedures where they have
- relevant technical skills and experience
- ability to communicate effectively with their patients
- understanding and application of ethical standards required to practice in this area.
- The group would like to ensure that in the long term any changes made are reflected in the training of future surgeons.
- Developing a certification system – for surgeons to demonstrate whether they meet these standards
- Data collection – availability of outcomes data about cosmetic surgery
- Patient information – support decision-making through clear, credible and unbiased information for patients
This consultation document applies to the surgical end of the treatment spectrum and does not affect cosmetic treatments such as botox, fillers, dermaroller and peels.
However, recommendations have been made for improving our sector’s governance and numerous discussion groups are underway.
We in the non-surgical treatment sector watch these developments in the surgical sector with interest as it could inform the direction that we take for industry guidelines for non-invasive treatment.
Non-Surgical Treatment News
You will also find further information and industry updates on our websites:
Dr Tim Pearce, MBChB BSc (hons) MRCGP